Filing Details
- Accession Number:
- 0001181431-14-024110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-16 17:29:10
- Reporting Period:
- 2014-06-13
- Filing Date:
- 2014-06-16
- Accepted Time:
- 2014-06-16 17:29:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1375151 | Zogenix Inc. | ZGNX | Pharmaceutical Preparations (2834) | 205300780 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1024007 | L Cam Garner | C/O Zogenix, Inc. 12400 High Bluff Dr., Suite 650 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-13 | 30,000 | $1.66 | 326,750 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.